Hedef ve Amaç
The purpose of the MammaPrint 70 Gene Breast Cancer Recurrence Test is to identify which breast cancer patients do not need chemotherapy by examining the genetics of the tumor in 7 critical genetic pathways associated with breast cancer metastasis (70 primary genes, 465 reference genes). MammaPrint test is FDA Approved
The MammaPrint test, which is performed from paraffin tumor blocks, is an FDA (American Food and Drug Administration) approved test.